68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.

Marius E Mayerhoefer,Markus Raderer,Michael Weber,Wolfgang Lamm,Barbara Kiesewetter,Marcus Hacker,Lukas Nics,Stefan Schmitl,Doris Leithner,Hans-Juergen Wester,Alexander Haug

Clinical nuclear medicine（2023）

引用 0|浏览18

暂无评分

摘要

In MCL patients, 68Ga-pentixafor PET may be superior for assessment of complete remission status than anatomic MRI using lesion size criteria, especially at the end of treatment.

查看译文

关键词

CXCR4, PET, MRI, lymphoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要